[go: up one dir, main page]

MX2009011444A - Titulacion del tapentadol. - Google Patents

Titulacion del tapentadol.

Info

Publication number
MX2009011444A
MX2009011444A MX2009011444A MX2009011444A MX2009011444A MX 2009011444 A MX2009011444 A MX 2009011444A MX 2009011444 A MX2009011444 A MX 2009011444A MX 2009011444 A MX2009011444 A MX 2009011444A MX 2009011444 A MX2009011444 A MX 2009011444A
Authority
MX
Mexico
Prior art keywords
tapentadol
titration
dose
administration unit
pain
Prior art date
Application number
MX2009011444A
Other languages
English (en)
Inventor
Claudia Lange
Ferdinand Rombout
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009011444(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of MX2009011444A publication Critical patent/MX2009011444A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesive Tapes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere al uso de tapentadol para la manufactura de un medicamento que comprende, al menos una unidad de administración A que contiene la dosis a de tapentadol y al menos una unidad de administración E que contiene la dosis b de tapentadol, en donde la dosis a < dosis b, para el tratamiento de dolor.
MX2009011444A 2007-04-23 2008-04-21 Titulacion del tapentadol. MX2009011444A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (en) 2007-04-23 2007-04-23 Titration of tapentadol
PCT/EP2008/003178 WO2008128740A1 (en) 2007-04-23 2008-04-21 Titration of tapentadol

Publications (1)

Publication Number Publication Date
MX2009011444A true MX2009011444A (es) 2009-11-05

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011444A MX2009011444A (es) 2007-04-23 2008-04-21 Titulacion del tapentadol.

Country Status (21)

Country Link
US (4) US20090012180A1 (es)
EP (5) EP1985292A1 (es)
JP (4) JP5933176B2 (es)
KR (3) KR20150027840A (es)
CN (1) CN101730530B (es)
AT (1) ATE534378T1 (es)
AU (1) AU2008241013B2 (es)
CA (1) CA2683786C (es)
CY (1) CY1112320T1 (es)
DK (1) DK2148670T3 (es)
ES (1) ES2378255T3 (es)
HR (1) HRP20120147T1 (es)
IL (1) IL201479A (es)
MX (1) MX2009011444A (es)
NZ (1) NZ580415A (es)
PL (1) PL2148670T3 (es)
PT (1) PT2148670E (es)
RU (1) RU2472497C2 (es)
SI (1) SI2148670T1 (es)
WO (1) WO2008128740A1 (es)
ZA (1) ZA200907355B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
DK2352494T3 (da) * 2008-10-30 2019-10-28 Gruenenthal Gmbh Nye og potente tapentadoldoseringsformer
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) * 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
WO2011138037A2 (de) * 2010-05-05 2011-11-10 Ratiopharm Gmbh Festes tapentadol in nicht-kristalliner form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
HRP20161166T1 (hr) * 2010-06-30 2016-11-04 Grünenthal GmbH Tapentadol za uporabu u liječenju sindroma iritabilnog crijeva
EP3656765B1 (en) * 2010-07-23 2021-04-14 Grünenthal GmbH Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
RS56692B1 (sr) 2011-03-04 2018-03-30 Gruenenthal Gmbh Polučvrsta vodena farmaceutska kompozicija koja sadrži tapentadol
PT2680832T (pt) 2011-03-04 2019-10-28 Gruenenthal Gmbh Formulação farmacêutica aquosa de tapentadol para administração oral
MX348831B (es) * 2011-03-04 2017-06-30 Gruenenthal Gmbh Administración parenteral de tapentadol.
EP2694050B1 (en) * 2011-04-05 2019-10-02 Grünenthal GmbH Tapentadol for use in treating pain associated with trigeminal neuralgia
WO2012136349A1 (en) * 2011-04-05 2012-10-11 Grünenthal GmbH Tapentadol for preventing chronification of pain
RS60152B1 (sr) 2011-04-29 2020-05-29 Gruenenthal Gmbh Tapentadol za sprečavanje i lečenje depresije i anksioznosti
JP6255474B2 (ja) * 2013-03-15 2017-12-27 マリンクロッド エルエルシー 機能的割線を有する即時放出用の乱用抑止性固体剤形
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
HRP20190231T1 (hr) 2015-03-27 2019-04-05 Grünenthal GmbH Stabilna formulacija za parenteralnu primjenu tapentadola
CN107660147B (zh) * 2015-05-26 2021-04-30 抗菌技术生物技术研究与发展股份有限公司 用于治疗帕金森病和相关障碍的组合物
BR112018017167A2 (pt) * 2016-02-29 2019-01-02 Gruenenthal Gmbh titulação de cebranopadol
JP7160799B2 (ja) 2016-09-23 2022-10-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口投与用安定製剤
AU2021237693A1 (en) 2020-03-16 2022-09-08 Grünenthal GmbH Scored tablet
KR20230156952A (ko) * 2021-03-17 2023-11-15 액테리온 파마슈티칼 리미티드 약제 투여 시스템
EP4333820A1 (en) * 2021-05-07 2024-03-13 Grünenthal GmbH Tapentadol for treating neuropathic pain in covid-19 patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
MXPA05006334A (es) 2002-12-13 2005-08-26 Euro Celtique Sa Dosis de buprenorfina transdermica para analgesia.
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
DE102007019417A1 (de) 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose

Also Published As

Publication number Publication date
ATE534378T1 (de) 2011-12-15
IL201479A (en) 2016-04-21
JP5933176B2 (ja) 2016-06-08
EP2148670A1 (en) 2010-02-03
EP3603630A1 (en) 2020-02-05
PT2148670E (pt) 2012-01-24
IL201479A0 (en) 2010-05-31
HK1140940A1 (en) 2010-10-29
NZ580415A (en) 2012-04-27
US20190290603A1 (en) 2019-09-26
CA2683786C (en) 2021-10-26
CY1112320T1 (el) 2015-12-09
EP3143993A1 (en) 2017-03-22
EP2148670B1 (en) 2011-11-23
JP2010531296A (ja) 2010-09-24
AU2008241013A1 (en) 2008-10-30
DK2148670T3 (da) 2012-03-12
RU2472497C2 (ru) 2013-01-20
KR20180004839A (ko) 2018-01-12
JP2019131598A (ja) 2019-08-08
PL2148670T3 (pl) 2012-04-30
JP2016128468A (ja) 2016-07-14
US20160074342A1 (en) 2016-03-17
AU2008241013B2 (en) 2013-06-20
RU2009142940A (ru) 2011-05-27
WO2008128740A1 (en) 2008-10-30
US20170079938A1 (en) 2017-03-23
CN101730530A (zh) 2010-06-09
CN101730530B (zh) 2013-10-23
EP2422778A1 (en) 2012-02-29
KR102078999B1 (ko) 2020-02-19
KR20100017267A (ko) 2010-02-16
EP1985292A1 (en) 2008-10-29
ES2378255T3 (es) 2012-04-10
CA2683786A1 (en) 2008-10-30
WO2008128740A8 (en) 2010-06-17
US11344512B2 (en) 2022-05-31
KR20150027840A (ko) 2015-03-12
HRP20120147T1 (hr) 2012-03-31
SI2148670T1 (sl) 2012-03-30
JP2018030864A (ja) 2018-03-01
US20090012180A1 (en) 2009-01-08
ZA200907355B (en) 2010-08-25

Similar Documents

Publication Publication Date Title
MX2009011444A (es) Titulacion del tapentadol.
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
MX2010009222A (es) Soluciones farmaceuticas, proceso de preparacion y usos terapeuticos.
MX2009013989A (es) Terapia en combinacion para depresion.
MY153408A (en) Novel methods
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
PH12013501790B1 (en) Use of dpp iv inhibitors
NZ707377A (en) Combination therapy methods for treating proliferative diseases
UA94734C2 (ru) ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
NZ591873A (en) Co-crystals of tramadol and nsaids
TN2012000515A1 (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
NZ715686A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
MX2010002735A (es) Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.
MX352824B (es) Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación.
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
MX2009008108A (es) Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno.
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
WO2007135123A3 (en) Mirtazapine for the treatment of neuropathic pain
EA201000738A1 (ru) Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата
AR048460A1 (es) Tratamiento de la funcion respiratoria alterada con gaboxadol
MX2008011017A (es) Compuestos de receptor sigma.
MX2008000780A (es) Combinacion terapeutica que comprende un bloqueador de receptores nmda y una sustancia narcotica analgesica.

Legal Events

Date Code Title Description
FG Grant or registration